These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
274 related articles for article (PubMed ID: 17569115)
41. N-myc downstream regulated 1 gene and its place in the cellular machinery. Kitowska A; Pawełczyk T Acta Biochim Pol; 2010; 57(1):15-21. PubMed ID: 20300662 [TBL] [Abstract][Full Text] [Related]
42. NDRG1 as a biomarker for metastasis, recurrence and of poor prognosis in hepatocellular carcinoma. Cheng J; Xie HY; Xu X; Wu J; Wei X; Su R; Zhang W; Lv Z; Zheng S; Zhou L Cancer Lett; 2011 Nov; 310(1):35-45. PubMed ID: 21763068 [TBL] [Abstract][Full Text] [Related]
43. Upregulation of NDRG1 predicts poor outcome and facilitates disease progression by influencing the EMT process in bladder cancer. Li A; Zhu X; Wang C; Yang S; Qiao Y; Qiao R; Zhang J Sci Rep; 2019 Mar; 9(1):5166. PubMed ID: 30914736 [TBL] [Abstract][Full Text] [Related]
44. Clinicopathological significance and linkage of the distribution of HIF-1alpha and GLUT-1 in human primary colorectal cancer. Wincewicz A; Sulkowska M; Koda M; Sulkowski S Pathol Oncol Res; 2007; 13(1):15-20. PubMed ID: 17387384 [TBL] [Abstract][Full Text] [Related]
45. Leptin expression correlates with favorable clinicopathologic phenotype and better prognosis in colorectal adenocarcinoma. Paik SS; Jang SM; Jang KS; Lee KH; Choi D; Jang SJ Ann Surg Oncol; 2009 Feb; 16(2):297-303. PubMed ID: 19050975 [TBL] [Abstract][Full Text] [Related]
46. A new facet of NDRG1 in pancreatic ductal adenocarcinoma: Suppression of glycolytic metabolism. Liu W; Zhang B; Hu Q; Qin Y; Xu W; Shi S; Liang C; Meng Q; Xiang J; Liang D; Ji S; Liu J; Hu P; Liu L; Liu C; Long J; Ni Q; Yu X; Xu J Int J Oncol; 2017 May; 50(5):1792-1800. PubMed ID: 28350132 [TBL] [Abstract][Full Text] [Related]
47. Analysis of the immunohistochemical expressions of p53, bcl-2 and Ki-67 in colorectal adenocarcinoma and their correlations with the prognostic factors. Menezes HL; Jucá MJ; Gomes EG; Nunes BL; Costa HO; Matos D Arq Gastroenterol; 2010; 47(2):141-7. PubMed ID: 20721457 [TBL] [Abstract][Full Text] [Related]
48. Discordance between EGFR expression and clinicopathologic parameters of colorectal adenocarcinoma in Taiwan. Tsai WC; Lin CK; Lee HS; Chen A; Nieh S; Yu CP; Wu CC; Jao SW; Jin JS Chin J Physiol; 2012 Oct; 55(5):352-60. PubMed ID: 23282210 [TBL] [Abstract][Full Text] [Related]
49. NDRG1 Downregulates ATF3 and Inhibits Cisplatin-Induced Cytotoxicity in Lung Cancer A549 Cells. Du A; Jiang Y; Fan C Int J Med Sci; 2018; 15(13):1502-1507. PubMed ID: 30443171 [TBL] [Abstract][Full Text] [Related]
50. The metastatic suppressor NDRG1 inhibits EMT, migration and invasion through interaction and promotion of caveolin-1 ubiquitylation in human colorectal cancer cells. Mi L; Zhu F; Yang X; Lu J; Zheng Y; Zhao Q; Wen X; Lu A; Wang M; Zheng M; Ji J; Sun J Oncogene; 2017 Jul; 36(30):4323-4335. PubMed ID: 28346422 [TBL] [Abstract][Full Text] [Related]
51. Nuclear accumulation of p53 in colorectal adenocarcinoma: prognostic importance differs with race and location of the tumor. Manne U; Weiss HL; Myers RB; Danner OK; Moron C; Srivastava S; Grizzle WE Cancer; 1998 Dec; 83(12):2456-67. PubMed ID: 9874449 [TBL] [Abstract][Full Text] [Related]
52. Semaphorin 4D and hypoxia-inducible factor-1α overexpression is related to prognosis in colorectal carcinoma. Wang JS; Jing CQ; Shan KS; Chen YZ; Guo XB; Cao ZX; Mu LJ; Peng LP; Zhou ML; Li LP World J Gastroenterol; 2015 Feb; 21(7):2191-8. PubMed ID: 25717256 [TBL] [Abstract][Full Text] [Related]
53. NDRG1 regulates neutral lipid metabolism in breast cancer cells. Sevinsky CJ; Khan F; Kokabee L; Darehshouri A; Maddipati KR; Conklin DS Breast Cancer Res; 2018 Jun; 20(1):55. PubMed ID: 29898756 [TBL] [Abstract][Full Text] [Related]
54. Prognostic significance of NDRG1 expression in oral and oropharyngeal squamous cell carcinoma. Dos Santos M; da Cunha Mercante AM; Nunes FD; Leopoldino AM; de Carvalho MB; Gazito D; López RV; Chiappini PB; de Carvalho Neto PB; Fukuyama EE; ; Tajara EH; Louro ID; da Silva AM Mol Biol Rep; 2012 Dec; 39(12):10157-65. PubMed ID: 22972152 [TBL] [Abstract][Full Text] [Related]
55. Correlation between NDRG1 and PTEN expression in endometrial carcinoma. Chen J; Li S; Yang Z; Lu G; Hu H Cancer Sci; 2008 Apr; 99(4):706-10. PubMed ID: 18377423 [TBL] [Abstract][Full Text] [Related]
56. The clinicopathological significance of REIC expression in colorectal carcinomas. Wang W; Zhu W; Xu XY; Nie XC; Yang X; Xing YN; Yu M; Liu YP; Takano Y; Zheng HC Histol Histopathol; 2012 Jun; 27(6):735-43. PubMed ID: 22473694 [TBL] [Abstract][Full Text] [Related]
57. P21WAF1/CIP1 expression in colorectal carcinomas is related to Kras mutations and prognosis. Mitomi H; Ohkura Y; Fukui N; Kanazawa H; Kishimoto I; Nakamura T; Yokoyama K; Sada M; Kobayashi K; Tanabe S; Saigenji K Eur J Gastroenterol Hepatol; 2007 Oct; 19(10):883-9. PubMed ID: 17873613 [TBL] [Abstract][Full Text] [Related]
58. Immunohistochemical expression of bcl-2 in UICC stage I and III colorectal carcinoma patients: correlation with c-erbB-2, p53, ki-67, CD44, laminin and collagen IV in evaluating prognostic significance. Zavrides H; Zizi-Sermpetzoglou A; Elemenoglou I; Papatheofanis I; Peros G; Athanasas G; Panousopoulos D Pol J Pathol; 2006; 57(3):149-59. PubMed ID: 17219742 [TBL] [Abstract][Full Text] [Related]
59. Overexpression of NDRG1 is an indicator of poor prognosis in hepatocellular carcinoma. Chua MS; Sun H; Cheung ST; Mason V; Higgins J; Ross DT; Fan ST; So S Mod Pathol; 2007 Jan; 20(1):76-83. PubMed ID: 17170744 [TBL] [Abstract][Full Text] [Related]
60. NDRG1 regulates Filopodia-induced Colorectal Cancer invasiveness via modulating CDC42 activity. Aikemu B; Shao Y; Yang G; Ma J; Zhang S; Yang X; Hong H; Yesseyeva G; Huang L; Jia H; Wang C; Zang L; Sun J; Zheng M Int J Biol Sci; 2021; 17(7):1716-1730. PubMed ID: 33994856 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]